Abeona Therapeutics (ABEO) Tops Q1 EPS by 13c

Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.24), $0.13 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c